%E1%88%8A%E1%88%9D%E1%8D%8B%E1%89%B2%E1%8A%AD_%E1%8D%8D%E1%88%8B%E1%88%AA%E1%8B%AB%E1%88%B2%E1%88%B5%D8%AF%D8%A7%D8%A1_%D8%A7%D9%84%D9%81%D9%8A%D9%84Fil_x%C9%99st%C9%99liyi%D0%9B%D0%B8%D0%BC%D1%84%D0%B0%D1%82%D0%B8%D1%87%D0%BD%D0%B0_%D1%84%D0%B8%D0%BB%D0%B0%D1%80%D0%B8%D0%BE%D0%B7%D0%B0Filariosi_limf%C3%A0ticaCategory:Lymphatic_filariasisElephantiasisLymphatic_filariasisL%C3%BCmfisoonte_filarioos%D9%BE%DB%8C%D9%84%E2%80%8C%D9%BE%D8%A7%DB%8C%DB%8CFilariose_lymphatique%D7%A4%D7%99%D7%9C%D7%90%D7%A8%D7%99%D7%90%D7%96%D7%99%D7%A1_%D7%9C%D7%99%D7%9E%D7%A4%D7%98%D7%99%D7%AA%E0%A4%AB%E0%A5%80%E0%A4%B2%E0%A4%AA%E0%A4%BE%E0%A4%81%E0%A4%B5Limfati%C4%8Dka_filarijazaElefanti%C3%A1zis%D5%93%D5%B2%D5%A1%D5%AD%D5%BFFilariasi_linfatica%D0%AD%D0%BB%D0%B5%D1%84%D0%B0%D0%BD%D1%82%D0%B8%D0%B0%D0%B7%EB%A6%BC%ED%94%84%EC%82%AC%EC%83%81%EC%B6%A9%EC%A6%9DDramblialig%C4%97%D0%9B%D0%B8%D0%BC%D1%84%D0%BD%D0%B0_%D1%84%D0%B8%D0%BB%D0%B0%D1%80%D0%B8%D1%98%D0%B0%D0%B7%D0%B0Untut%E1%80%86%E1%80%84%E1%80%BA%E1%80%81%E1%80%BC%E1%80%B1%E1%80%91%E1%80%B1%E1%80%AC%E1%80%80%E1%80%BA%E1%80%9B%E1%80%B1%E1%80%AC%E1%80%82%E1%80%AB%E0%A4%B9%E0%A4%BE%E0%A4%A4%E0%A5%8D%E0%A4%A4%E0%A5%80%E0%A4%AA%E0%A4%BE%E0%A4%87%E0%A4%B2%E0%A5%87_%E0%A4%B0%E0%A5%8B%E0%A4%97Elefantiase%E0%AC%97%E0%AD%8B%E0%AC%A6%E0%AC%B0_%E0%AC%B0%E0%AD%8B%E0%AC%97Filar%C3%ADase_linf%C3%A1ticaFilarioz%C4%83_limfatic%C4%83%D0%AD%D0%BB%D0%B5%D1%84%D0%B0%D0%BD%D1%82%D0%B8%D0%B0%D0%B7ElefantiazaElefantiasisMatende%E0%AE%AF%E0%AE%BE%E0%AE%A9%E0%AF%88%E0%AE%95%E0%AF%8D%E0%AE%95%E0%AE%BE%E0%AE%B2%E0%AF%8D_%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B9%80%E0%B8%97%E0%B9%89%E0%B8%B2%E0%B8%8A%E0%B9%89%E0%B8%B2%E0%B8%87Lymphatic_filariasisFil_hastal%C4%B1%C4%9F%C4%B1%D0%9B%D1%96%D0%BC%D1%84%D0%B0%D1%82%D0%B8%D1%87%D0%BD%D1%96_%D1%84%D1%96%D0%BB%D1%8F%D1%80%D1%96%D1%97%D0%B4%D0%BE%D0%B7%D0%B8B%E1%BB%87nh_giun_ch%E1%BB%89_b%E1%BA%A1ch_huy%E1%BA%BFtFiyaireQ192100
about
P2175
P509
P828
The global programme to eliminate lymphatic filariasis: health impact after 8 yearsThe Effect of Hygiene-Based Lymphedema Management in Lymphatic Filariasis-Endemic Areas: A Systematic Review and Meta-analysisMultidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of wormsDisability measurement for lymphatic filariasis: a review of generic tools used within morbidity management programsLymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011.Anti-Wolbachia drug discovery and development: safe macrofilaricides for onchocerciasis and lymphatic filariasisA review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasisA systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa.The emerging story of disability associated with lymphatic filariasis: a critical reviewFilariasis and lymphoedema.Urban lymphatic filariasis.Population migration: implications for lymphatic filariasis elimination programmes.Global elimination of lymphatic filariasis: a "mass uprising of compassion".Climate Change and Spatiotemporal Distributions of Vector-Borne Diseases in Nepal--A Systematic Synthesis of Literature.Fifteen years of programme implementation for the elimination of Lymphatic Filariasis in Ghana: Impact of MDA on immunoparasitological indicatorsCompliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review.Lymphatic filariasis in Brazil: epidemiological situation and outlook for eliminationSelf-Care for Management of Secondary Lymphedema: A Systematic Review.Successful control of lymphatic filariasis in the Republic of Korea.Diversity and transmission competence in lymphatic filariasis vectors in West Africa, and the implications for accelerated elimination of Anopheles-transmitted filariasisAn investigation of the disparity in estimates of microfilaraemia and antigenaemia in lymphatic filariasis surveys.Impact of polystyrene beads as a mosquito control measure to supplement lymphatic filariasis elimination activities in Socotra Island, Yemen.Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs.Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review.High Throughput and Computational Repurposing for Neglected DiseasesMicrobial exopolymer-capped selenium nanowires - Towards new antibacterial, antibiofilm and arbovirus vector larvicides?Potential factors influencing lymphatic filariasis transmission in "hotspot" and "control" areas in Ghana: the importance of vectorsFlubendazole as a macrofilaricide: History and backgroundElimination of lymphatic filariasis as a public health problem in Niue under PacELF, 1999-2016Risk factors for lymphatic filariasis in two villages of the Democratic Republic of the CongoThe Global Burden of Disease of Zoonotic Parasitic Diseases: Top 5 Contenders for Priority ConsiderationAssessing the Presence of Infections in Vectors Using Xenomonitoring in Lymphatic Filariasis Endemic Districts in GhanaProfiling the best-performing community medicine distributors for mass drug administration: a comprehensive, data-driven analysis of treatment for schistosomiasis, lymphatic filariasis, and soil-transmitted helminths in UgandaThe authors' reply to "Both Macro and Micro Filarial Treatment May be Necessary to Treat Hydrocele Due to a Wuchereria bancrofti Infection"The Effect of a Regimen of Antifungal Cream Use on Episodes of Acute Adenolymphangitis (ADL) among Lymphedema Patients: An Application Using Marginal Structural ModelsPreventive chemotherapy reverses covert, lymphatic-associated tissue change in young people with lymphatic filariasis in MyanmarHydrocele due to Wuchereria bancrofti InfectionImmunological evaluation of fusion protein of abundant larval protein transcript-2 (BmALT-2) and Tuftsin in experimental mice modelInfluence of seasonal variation on reported filarial attacks among people living with lymphedema in Ghana
P921
description
abnorme Vergrößerung eines Körperteils
@de
human disease caused by parasitic worms
@en
maladie
@fr
malattia
@it
sairaus
@fi
tropska helmintiaza
@sl
група тропічних гельмінтозів
@uk
מחלה
@he
熱帯虫症。寄生性フィラリア類の寄生による後遺症の一つ。
@ja
name
Bệnh giun chỉ bạch huyết
@vi
Dramblialigė
@lt
Eilifintiáis
@ga
Elefantiasis
@da
Elefantiasis
@nb
Elefantiasis
@nl
Elefantiazis
@ro
Elefantiazo
@io
Elefantijaza
@sh
Elefantijaza
@sr-el
type
label
Bệnh giun chỉ bạch huyết
@vi
Dramblialigė
@lt
Eilifintiáis
@ga
Elefantiasis
@da
Elefantiasis
@nb
Elefantiasis
@nl
Elefantiazis
@ro
Elefantiazo
@io
Elefantijaza
@sh
Elefantijaza
@sr-el
altLabel
Bancroftian elephantiasis (disorder)
@en
Bancroftian elephantiasis
@en
Bancroftian filarial chyluria
@en
Elefancia
@es
Elefancía
@es
Elefantenkrankheit
@de
Elefantenmann-Syndrom
@de
Elefantiaasi
@fi
Elefantiase
@nl
Elefantiasi
@it
prefLabel
Bệnh giun chỉ bạch huyết
@vi
Dramblialigė
@lt
Eilifintiáis
@ga
Elefantiasis
@da
Elefantiasis
@nb
Elefantiasis
@nl
Elefantiazis
@ro
Elefantiazo
@io
Elefantijaza
@sh
Elefantijaza
@sr-el
